Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 8.27 BATS BZX Real-Time Price As of 11:13am ET |  -0.37 / -4.28%Today’s Change | 1.67 Today|||52-Week Range 8.74 | +31.90% Year-to-Date |
Institutional investors purchased a net $770.9 thousand shares of CBAY during the quarter ended June 2019, and now own 70.14% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Mutual fund holders | 9.96% |
| Other institutional | 60.18% |
| Individual stakeholders | 12.92% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/30/2022 | APO ASSET MANAGEMENT GMBH Bought 60.0 Thousand shares of Cymabay Therapeutics Inc |
| 1/05/2023 | MIRAE ASSET GLOBAL INVESTMENTS C... Bought 113.00 shares of Cymabay Therapeutics Inc |
| 12/31/2022 | DFA AUSTRALIA LTD. Bought 11.00 shares of Cymabay Therapeutics Inc |
Top 10 Owners of Cymabay Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Avoro Capital Advisor LLC | 12.16% | 10,300,000 | 64,581,000 | 0 | 0.00% |
| TCG Crossover Management LLC | 6.97% | 5,905,400 | 37,026,858 | 0 | 0.00% |
| Commodore Capital LP | 6.78% | 5,738,500 | 35,980,395 | 0 | 0.00% |
| The Vanguard Group, Inc. | 4.29% | 3,631,909 | 22,772,069 | +108,020 | +3.07% |
| Nantahala Capital Management LLC | 2.92% | 2,474,659 | 15,516,112 | -169,647 | -6.42% |
| Lynx1 Capital Management LP | 2.75% | 2,325,833 | 14,582,973 | -263,846 | -10.19% |
| Baker Bros. Advisors LP | 2.56% | 2,170,464 | 13,608,809 | 0 | 0.00% |
| BlackRock Fund Advisors | 2.23% | 1,888,905 | 11,843,434 | -8,462 | -0.45% |
| Altium Capital Management LP | 2.07% | 1,750,000 | 10,972,500 | 0 | 0.00% |
| DAFNA Capital Management LLC | 2.01% | 1,703,235 | 10,679,283 | -84,334 | -4.72% |
Top 10 Mutual Funds Holding Cymabay Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index... | 2.83% | 2,398,201 | 15,036,720 | 0 | 0.00% |
| Vanguard Extended Market Index Fu... | 1.33% | 1,121,963 | 7,034,708 | +10,236 | +0.92% |
| FCP Medical - BioHealth | 0.90% | 760,005 | 4,765,231 | 0 | 0.00% |
| iShares Biotechnology ETF | 0.78% | 661,963 | 4,150,508 | +2,485 | +0.38% |
| Fidelity Extended Market Index Fu... | 0.47% | 398,563 | 2,498,990 | 0 | 0.00% |
| DFA US Small Cap Portfolio | 0.42% | 352,597 | 2,210,783 | +77,546 | +28.19% |
| APO Medical Opportunities | 0.35% | 294,298 | 1,845,248 | +60,000 | +25.61% |
| DFA US Micro Cap Portfolio | 0.33% | 275,879 | 1,729,761 | +123,772 | +81.37% |
| iShares Tr. - Micro Cap ETF | 0.21% | 178,466 | 1,118,982 | 0 | 0.00% |
| Fidelity Total Market Index Fund | 0.17% | 140,868 | 883,242 | 0 | 0.00% |